ASK REDCHAT ANYTHING ABOUT AVALO THERAPEUTICS INC.
Avalo Therapeutics Inc. (NASDAQ: AVTX)
Listen to this Section
$13.08
-0.5300
(
-3.89% )
946.4K
Sign up for The Small Stocks Big Money Newsletter and receive free small-cap news and insights.
Clinical Trial Pipeline Stages
| Drug Name |
Stage |
| AVTX-803 (CERC-803)DetailsLeukocyte Adhesion Deficiency Type II |
Phase 3 |
| AVTX-009DetailsHidradenitis suppurativa, Autoimmune disease |
Phase 2 |
| Quisovalimab/ AVTX-002 (CERC-002)DetailsCOVID-19 |
Phase 2 |
| Quisovalimab/AVTX-002 (CERC-002)DetailsAsthma |
Phase 2 |
| AVTX-007 (CERC-007)DetailsMultiple myeloma, Adult Onset Still's Disease |
Phase 1b |
| Quisovalimab/ AVTX-002 (CERC-002)DetailsCrohns disease |
Phase 1b |
| AVTX-801 (CERC-801)DetailsMetabolic disorder, Rare genetic disease |
Failed |
| AVTX-802 (CERC-802)DetailsMetabolic disorder, Rare genetic disease |
Failed |
| AVTX-006 (CERC-006)DetailsLymphatic malformations |
Failed |
Market Data
|
| Open |
$13.08 |
| Previous Close |
$13.61 |
| Volume |
946.4K |
| Market Cap |
$722.25M |
| Day Range |
$13.08 - $14.70 |
| 52 Week Range |
$4.06 - $24.27 |
| Shares Outstanding |
52.57M |
| Change % |
-3.89% |
| Net Change |
▼ -0.5300 |
| Insider Ownership |
-0.10% |
| Exchange |
NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology: Pharmaceutical Preparations |
| IPO Year | 2015 |
| Country | United States |
Insider Ownership Transactions
Total Amount Purchased:
-1,231,536.00
| Date |
Type |
Amount Purchased |
Purchaser |
| 2024-11-14 |
Buy |
500.00 |
Almenoff June Sherie |
| 2024-08-14 |
Sale |
-24600.00 |
Goldman Jonathan |
| 2024-08-14 |
Sale |
-24600.00 |
Chan Mitchell |
| 2024-08-14 |
Sale |
-24600.00 |
Almenoff June Sherie |
| 2024-08-14 |
Sale |
-24600.00 |
KANTOFF AARON |
| 2024-08-14 |
Sale |
-24600.00 |
Truex Samantha |
| 2024-08-14 |
Sale |
-24600.00 |
KAPLAN GILLA |
| 2024-08-14 |
Sale |
-186700.00 |
Sullivan Christopher Ryan |
| 2024-08-14 |
Sale |
-500400.00 |
NEIL GARRY ARTHUR |
| 2024-07-16 |
Sale |
-234000.00 |
Doyle Mittie |
SEC Filings
| Form Type |
Description |
Pages |
Date |
| 8-k |
8K-related |
38 |
Jun 04, 2025 |